Cytokine Panel 13, CSF
Use
Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders. Results are used to understand the pathophysiology of these conditions and may be employed for research purposes. This test is developed and its performance characteristics determined by ARUP Laboratories. It is intended for clinical purposes and has not been cleared or approved by the US Food and Drug Administration.
Special Instructions
Cytokine levels may demonstrate diurnal variation. For longitudinal comparison, it is recommended that cytokine levels be determined at the same time of day.
Limitations
This test was developed as a Laboratory Developed Test (LDT) and its performance characteristics were determined by ARUP Laboratories. The test has not been cleared or approved by the US Food and Drug Administration. It is performed in a CLIA certified laboratory for clinical purposes.
New York Approved
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
LOINC Codes
- 99764-3
- 49909-5
- 99765-0
- 70089-8
- 99766-8
- 99767-6
- 70077-3
- 99768-4
- 70083-1
- 70084-9
- 49919-4
- 99769-2
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP Standard Transport Tube
Storage Instructions
CRITICAL FROZEN. Ship in an ARUP Standard Transport Tube.
Causes for Rejection
Refrigerated specimens. Contaminated or heat inactivated specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 minutes |
| Refrigerated | Unacceptable |
| Frozen | 1 month |